Which statement best describes the mechanism shared by Clonidine, Methyldopa, and Guanfacine?

Which statement best describes the mechanism shared by Clonidine, Methyldopa, and Guanfacine?

• A. Target CNS Alpha-2 receptors and decrease sympathetic outflow, causing vasodilation
• B. Block peripheral Alpha-1 receptors
• C. Directly inhibit renin release
• D. Act as diuretics

Answer: (A)

These drugs share a central mechanism: they activate alpha-2 adrenergic receptors in the brain, which decreases sympathetic outflow. With less sympathetic nerve activity, there’s reduced release of norepinephrine onto blood vessels, leading to vasodilation and lower blood pressure. Clonidine acts directly on CNS alpha-2 receptors to suppress sympathetic discharge. Methyldopa is taken up into the CNS and converted to alpha-methylnorepinephrine, a false transmitter that stimulates central alpha-2 receptors. Guanfacine is a selective CNS alpha-2 receptor agonist. This central mechanism explains their antihypertensive effects, in contrast to peripheral alpha-1 blockade, direct renin-angiotensin system inhibition, or diuretic effects, which involve different pathways.

These drugs share a central mechanism: they activate alpha-2 adrenergic receptors in the brain, which decreases sympathetic outflow. With less sympathetic nerve activity, there’s reduced release of norepinephrine onto blood vessels, leading to vasodilation and lower blood pressure.

Clonidine acts directly on CNS alpha-2 receptors to suppress sympathetic discharge. Methyldopa is taken up into the CNS and converted to alpha-methylnorepinephrine, a false transmitter that stimulates central alpha-2 receptors. Guanfacine is a selective CNS alpha-2 receptor agonist.

This central mechanism explains their antihypertensive effects, in contrast to peripheral alpha-1 blockade, direct renin-angiotensin system inhibition, or diuretic effects, which involve different pathways.